David Shoshani

684 total citations
23 papers, 493 citations indexed

About

David Shoshani is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Dermatology. According to data from OpenAlex, David Shoshani has authored 23 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Psychiatry and Mental health and 6 papers in Dermatology. Recurrent topics in David Shoshani's work include Facial Rejuvenation and Surgery Techniques (6 papers), Schizophrenia research and treatment (6 papers) and Dermatologic Treatments and Research (5 papers). David Shoshani is often cited by papers focused on Facial Rejuvenation and Surgery Techniques (6 papers), Schizophrenia research and treatment (6 papers) and Dermatologic Treatments and Research (5 papers). David Shoshani collaborates with scholars based in Israel, United States and Belgium. David Shoshani's co-authors include Elana Markovitz, Shlomo Laniado, Stan Monstrey, Bernard Belhassen, Amir Pelleg, Bernard Belhassen, H C Miller, Itzhak Shapira, Yaël C. Cohen and Michael Schneidman and has published in prestigious journals such as Circulation, Blood and Biological Psychiatry.

In The Last Decade

David Shoshani

23 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Shoshani Israel 11 240 139 108 57 53 23 493
Robert A. Axford-Gatley Canada 13 40 0.2× 163 1.2× 135 1.3× 10 0.2× 24 0.5× 18 373
Filadelfo Coniglione Italy 11 42 0.2× 30 0.2× 162 1.5× 21 0.4× 31 0.6× 30 357
Amita Goyal United States 9 99 0.4× 13 0.1× 52 0.5× 7 0.1× 60 1.1× 10 389
Abdullah Cindaş Türkiye 9 28 0.1× 7 0.1× 126 1.2× 61 1.1× 31 0.6× 13 384
Anca Ionescu Romania 8 28 0.1× 12 0.1× 40 0.4× 11 0.2× 23 0.4× 19 206
C. Uhlemann Germany 8 17 0.1× 7 0.1× 75 0.7× 127 2.2× 26 0.5× 31 398
Molly S Jain United States 8 13 0.1× 9 0.1× 88 0.8× 20 0.4× 28 0.5× 23 249
Charles Joussain France 10 39 0.2× 4 0.0× 21 0.2× 53 0.9× 7 0.1× 41 263
Brendan Alleyne United States 9 5 0.0× 56 0.4× 119 1.1× 105 1.8× 8 0.2× 27 348
Anna Straburzyńska‐Lupa Poland 13 43 0.2× 12 0.1× 19 0.2× 57 1.0× 35 0.7× 43 399

Countries citing papers authored by David Shoshani

Since Specialization
Citations

This map shows the geographic impact of David Shoshani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shoshani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shoshani more than expected).

Fields of papers citing papers by David Shoshani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shoshani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shoshani. The network helps show where David Shoshani may publish in the future.

Co-authorship network of co-authors of David Shoshani

This figure shows the co-authorship network connecting the top 25 collaborators of David Shoshani. A scholar is included among the top collaborators of David Shoshani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shoshani. David Shoshani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shoshani, David, et al.. (2008). The Modified Fitzpatrick Wrinkle Scale: A Clinical Validated Measurement Tool for Nasolabial Wrinkle Severity Assessment. Dermatologic Surgery. 34(s1). S85–S91. 77 indexed citations
3.
Shoshani, David, et al.. (2008). The Modified Fitzpatrick Wrinkle Scale. Dermatologic Surgery. 34. S85–S91. 4 indexed citations
4.
Shoshani, David, et al.. (2007). Skin Test Hypersensitivity Study of a Cross-linked, Porcine Collagen Implant for Aesthetic Surgery. Dermatologic Surgery. 33. S152–S158. 28 indexed citations
5.
Monstrey, Stan, S. Pitaru, Moustapha Hamdi, et al.. (2007). A Two-Stage Phase I Trial of Evolence30 Collagen for Soft-Tissue Contour Correction. Plastic & Reconstructive Surgery. 120(1). 303–311. 38 indexed citations
6.
Shoshani, David, et al.. (2007). Skin Test Hypersensitivity Study of a Cross-linked, Porcine Collagen Implant for Aesthetic Surgery. Dermatologic Surgery. 33(Supplement). S152–S158. 9 indexed citations
7.
Takagaki, Masami, Patrick M. McCarthy, Nicholas G. Smedira, et al.. (2001). A Novel Miniature Ventricular Assist Device for Hemodynamic Support. ASAIO Journal. 47(4). 412–416. 4 indexed citations
8.
Dossenbach, Martín, Robert H. Belmaker, Avner Elizur, et al.. (2000). The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine. Clinical Therapeutics. 22(9). 1021–1034. 39 indexed citations
9.
Geskes, Gijs, et al.. (1999). The enabler right ventricular circulatory support system for beating heart coronary artery bypass graft surgery. The Annals of Thoracic Surgery. 68(4). 1558–1561. 17 indexed citations
10.
Dorfman, Pierre, et al.. (1998). Olanzapine treatment after clozapine induced agranulocytosis. Human Psychopharmacology Clinical and Experimental. 13(8). 583–584. 4 indexed citations
11.
Poyurovsky, Michael, et al.. (1998). Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.. PubMed. 21(2). 97–100. 17 indexed citations
12.
Dossenbach, Martín, et al.. (1997). Olanzapine in patients with clozapine treatment failure. Biological Psychiatry. 42(1). 231S–231S. 1 indexed citations
13.
Tollefson, Gary D., Pierre V. Trân, Martin Birkett, & David Shoshani. (1997). Treatment failure with clozapine: Can olanzapine be the alternative therapy?. Schizophrenia Research. 24(1-2). 191–191. 2 indexed citations
14.
Shoshani, David, et al.. (1997). P.2.092 Clozapine-induced agranulocytosis: Can olanzapine be a safer alternative?. European Neuropsychopharmacology. 7. S221–S221. 1 indexed citations
15.
Barak, Yoram, Dan J. Stein, Joseph Levine, et al.. (1996). Thyroxine Augmentation of Fluoxetine Treatment for Resistant Depression in the Elderly: An Open Trial. Human Psychopharmacology Clinical and Experimental. 11(6). 463–467. 3 indexed citations
16.
Belhassen, Bernard, David Shoshani, & Shlomo Laniado. (1989). Unmasking of ventricular preexcitation by adenosine triphosphate: Its usefulness in the assessment of ajmaline test. American Heart Journal. 118(3). 634–636. 17 indexed citations
17.
Belhassen, Bernard, et al.. (1987). Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.. Circulation. 75(4). 809–816. 98 indexed citations
18.
Belhassen, Bernard, Amir Pelleg, David Shoshani, & Shlomo Laniado. (1984). Atrial fibrillation induced by adenosine triphosphate. The American Journal of Cardiology. 53(9). 1405–1406. 31 indexed citations
19.
Belhassen, Bernard, et al.. (1983). Electrophysiologic effects of adenosine-5'-triphosphate on atrioventricular reentrant tachycardia.. Circulation. 68(4). 827–833. 68 indexed citations
20.
Rotmensch, Heschi H., Brian N. Swanson, Arnold J. Greenspon, David Shoshani, & Allan M. Greenspan. (1983). Amiodarone: Individualizing Dosage with Serum Concentrations. Pacing and Clinical Electrophysiology. 6(6). 1327–1335. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Axford-Gatley Breakdown of academic impact, for papers by Filadelfo Coniglione Breakdown of academic impact, for papers by Amita Goyal Breakdown of academic impact, for papers by Abdullah Cindaş Breakdown of academic impact, for papers by Anca Ionescu Breakdown of academic impact, for papers by C. Uhlemann Breakdown of academic impact, for papers by Molly S Jain Breakdown of academic impact, for papers by Charles Joussain Breakdown of academic impact, for papers by Brendan Alleyne Breakdown of academic impact, for papers by Anna Straburzyńska‐Lupa
Rankless by CCL
2026